“Oral cancer in the U.S. is increasing,“
Approximately 40,000 Americans are diagnosed with oral cancer each year. Individuals at increased oral cancer risk include patients 40 years of age or older, and individuals between 18 to 39 years of age who smoke, engage in chronic alcohol consumption or are infected with Oral HPV 16/18.
During the ViziLite Plus screening, a pre-rinse solution is applied to make abnormal cells more visible. A handheld light source is then used to spot precancerous and cancerous cells that could be difficult to see during a regular examination. Normal tissue absorbs the light and abnormal tissue reflects it.
The patented ViziLite Plus technology has been clinically proven to help dentists and other healthcare professionals with oral cancer detection, evaluation and monitoring.
“We want to make sure all of our patients receive the best care possible when it comes to their oral health,” says Dr.Vold. “With wellness screenings like the ViziLite Plus test, we can detect oral cancer in its early stages and help saves lives.”
For more information on oral cancer and oral cancer screenings, visit the Northbrook Court Dental Associates web site (http://www.northbrookcourtdental.com), or call the office today at 847-272-2900. Dr. Vold also has another web site, http://www.digitaldenturesofchicago.com/
Dr. Michael Vold has a Bachelor of Science degree from the University of Wisconsin (1963), a Doctor of Dental Surgery degree from Northwestern University Dental School (1967) and a Juris Doctor degree from DePaul University College of Law (1980). He served as a dentist in the U.S. Air Force and taught as an Assistant Professor at the University of Illinois, College of Dentistry. Dr. Vold is a member of the American Dental Association and Illinois State Dental Society, as well as a recipient of numerous professional honors and awards.